Literature DB >> 19648161

Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.

Martin A Schumacher1, Roland Schmitz, Verena Brune, Enrico Tiacci, Claudia Döring, Martin-Leo Hansmann, Reiner Siebert, Ralf Küppers.   

Abstract

Nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL) shows constitutive NF-kappaB activity in the malignant lymphocyte-predominant (LP) cells. Constitutive NF-kappaB activity also plays a central pathogenetic role in classical Hodgkin's lymphoma (cHL), where inactivating mutations in the NFKBIA and TNFAIP3 genes, coding for the negative NF-kappaB regulators IkappaBalpha and A20, respectively, contribute to NF-kappaB activation. To determine whether mutations in NFKBIA and TNFAIP3 are also involved in the pathogenesis of NLPHL these genes were sequenced from microdissected LP cells of 10 primary NLPHL. We also studied DEV, the only cell line proposedly derived from LP cells, after we had confirmed its derivation from NLPHL by gene expression analysis. A heterozygous somatic missense mutation in the NFKBIA gene was found in one NLPHL, and a heterozygous, possibly subclonal, two base pair insertion in TNFAIP3 in another case. The low mutation frequency and the absence of biallelic destructive mutations propose a minor contribution of NFKBIA and TNFAIP3 mutations to the NF-kappaB activity of NLPHL, suggesting different mechanisms of NF-kappaB activation in NLPHL and cHL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648161      PMCID: PMC2805741          DOI: 10.3324/haematol.2009.010157

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  22 in total

1.  Analysis of p53 mutations in single cells obtained from histological tissue sections.

Authors:  A E Persson; G Ling; C Williams; H Bäckvall; J Pontén; F Pontén; J Lundeberg
Journal:  Anal Biochem       Date:  2000-12-01       Impact factor: 3.365

2.  Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.

Authors:  F Emmerich; M Meiser; M Hummel; G Demel; H D Foss; F Jundt; S Mathas; D Krappmann; C Scheidereit; H Stein; B Dörken
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

3.  Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.

Authors:  S M Chittal; P Caverivière; R Schwarting; J Gerdes; T Al Saati; F Rigal-Huguet; H Stein; G Delsol
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

4.  The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.

Authors:  H Y Song; M Rothe; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 5.  Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines.

Authors:  H G Drexler
Journal:  Leuk Lymphoma       Date:  1993-01

6.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

7.  Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas.

Authors:  Ewerton M Maggio; Anke Van Den Berg; Lydia Visser; Arjan Diepstra; Joust Kluiver; Roelke Emmens; Sibrand Poppema
Journal:  Int J Cancer       Date:  2002-06-10       Impact factor: 7.396

8.  Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.

Authors:  Annette Lake; Lesley A Shield; Pablo Cordano; Daniel T Y Chui; Julie Osborne; Shauna Crae; Katherine S Wilson; Sabrina Tosi; Samantha J L Knight; Stefan Gesk; Reiner Siebert; Ron T Hay; Ruth F Jarrett
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

9.  Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.

Authors:  Iwona Wlodarska; Peet Nooyen; Brigitte Maes; José I Martin-Subero; Reiner Siebert; Patrick Pauwels; Chris De Wolf-Peeters; Anne Hagemeijer
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

10.  Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells.

Authors:  S Poppema; B De Jong; J Atmosoerodjo; V Idenburg; L Visser; L De Ley
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

View more
  18 in total

1.  T-cell/histiocyte-rich large B-cell lymphoma.

Authors:  Stefania Pittaluga; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

Review 2.  [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

Authors:  S Hartmann; S Cogliatti; M-L Hansmann
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

Review 3.  A20: from ubiquitin editing to tumour suppression.

Authors:  Sarah G Hymowitz; Ingrid E Wertz
Journal:  Nat Rev Cancer       Date:  2010-04-12       Impact factor: 60.716

Review 4.  Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Authors:  Kian-Huat Lim; Yibin Yang; Louis M Staudt
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.

Authors:  Vincent Camus; Aspasia Stamatoullas; Sylvain Mareschal; Pierre-Julien Viailly; Nasrin Sarafan-Vasseur; Elodie Bohers; Sydney Dubois; Jean Michel Picquenot; Philippe Ruminy; Catherine Maingonnat; Philippe Bertrand; Marie Cornic; Valérie Tallon-Simon; Stéphanie Becker; Liana Veresezan; Thierry Frebourg; Pierre Vera; Christian Bastard; Hervé Tilly; Fabrice Jardin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

Review 6.  Hodgkin lymphoma.

Authors:  Ralf Küppers; Andreas Engert; Martin-Leo Hansmann
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

7.  A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.

Authors:  Lisa Giulino; Susan Mathew; Gianna Ballon; Amy Chadburn; Sharon Barouk; Giuseppina Antonicelli; Lorenzo Leoncini; Yi Fang Liu; Swarna Gogineni; Wayne Tam; Ethel Cesarman
Journal:  Blood       Date:  2011-03-15       Impact factor: 22.113

Review 8.  An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.

Authors:  Akira Satou; Taishi Takahara; Shigeo Nakamura
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

9.  Pathobiology of hodgkin lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudio Tripodo; Francesco Bacci; Elena Sabattini; Maria Teresa Sista; Claudia Mannu; Maria Rosaria Sapienza; Maura Rossi; Maria Antonella Laginestra; Carlo A Sagramoso-Sacchetti; Simona Righi; Stefano A Pileri
Journal:  Adv Hematol       Date:  2010-12-22

10.  Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma.

Authors:  Junko Nomoto; Nobuhiro Hiramoto; Motohiro Kato; Masashi Sanada; Akiko Miyagi Maeshima; Hirokazu Taniguchi; Fumie Hosoda; Yoshitaka Asakura; Wataru Munakata; Naohiro Sekiguchi; Dai Maruyama; Takashi Watanabe; Hitoshi Nakagama; Kengo Takeuchi; Kensei Tobinai; Seishi Ogawa; Yukio Kobayashi
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.